Background: To investigate the influence of continuous positive airway pressure (CPAP) on
lipid profiles of the patients with obstructive sleep apnea (OSA) in this meta-analysis …

Purpose Dyslipidemia is considered as one mechanism causing cardiovascular sequelae in
obstructive sleep apnea (OSA). Continuous positive airway pressure (CPAP) can reduce …

Background Obstructive sleep apnea syndrome (OSAS) is an independent risk factor for
development of dyslipidemia. Continuous positive airway pressure (CPAP) is the first-line …

Background: Obstructive sleep apnea (OSA) is associated with dyslipidemia. However, the
effects of continuous positive airway pressure (CPAP) treatment on lipid profiles are unclear …

Continuous positive airway pressure (CPAP) provides a well‐documented symptomatic
relief for most patients with obstructive sleep apnea (OSA); however, its effect on …

Background and aim Obstructive sleep apnea (OSA) is an independent risk factor for
dyslipidemia. The current study examined the effects of positive airway pressure (PAP) …

Rationale: Dyslipidemia is common in Obstructive Sleep Apnea (OSA). Postprandial
lipidemia (PPL) is a strong marker of cardiovascular risk. Evidence that OSA treatment …

Background It is still controversial if the continuous positive airway pressure (CPAP)
treatment for patients with obstructive sleep apnea (OSA) can markedly influence an effect …

Obstructive sleep apnoea (OSA) is increasingly considered as a risk factor for metabolic
disturbances, such as diabetes mellitus or dyslipidaemia. Continuous positive airway …

Abstract Obstructive Sleep Apnoea (OSA) is a common disorder in adults. Its hallmark is
repetitive episodes of partial or complete obstruction of the upper airway during sleep …